BofA analyst Simona Sarli lowered the firm’s price target on Rentokil Initial to $28 from $30.50 and keeps a Neutral rating on the shares following Rentokil’s profit warning and sees more downside risk. The firm, which reduced its FY24 and FY25 EPS estimates by 9% and is 5% below consensus, says it sees even higher risk to free cash flow, where its estimates are 10%- 11% below the Street view.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RTO:
- Rentokil Initial downgraded to Hold from Buy at Stifel
- Rentokil Initial price target lowered to 550 GBp from 675 GBp at Citi
- Rentokil Initial price target lowered to 450 GBp from 500 GBp at JPMorgan
- Rentokil Initial price target lowered to 600 GBp from 640 GBp at Barclays
- Rentokil Initial price target lowered to 465 GBp from 550 GBp at Deutsche Bank
Questions or Comments about the article? Write to editor@tipranks.com